|
| 36921335 | Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer. | J Clin Oncol | 2023 |
| 37402878 | Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma. | | 2023 |
| 37339271 | Discordance of HER2 Expression and/or Amplification on Repeat Testing. | Mol Cancer Ther | 2023 |
| 37269905 | ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. | Ann Oncol | 2023 |
| 36884217 | Preclinical Efficacy of the Antibody-Drug Conjugate CLDN6-23-ADC for the Treatment of CLDN6-Positive Solid Tumors. | Clin Cancer Res | 2023 |
| 36631725 | Tumor biomarkers and efficacy in patients treated with trastuzumab emtansineâ¿¿+â¿¿pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE). | Breast Cancer Res | 2023 |
| 35000083 | Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer. | Annals of Surgical Oncology | 2022 |
| 36358657 | A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System. | Cancers (Basel) | 2022 |
| 35384873 | A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therap | Applied Immunohistochemistry and Molecular Morphology | 2022 |
| 35681773 | Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. | Cancers | 2022 |
| 35554533 | Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach. | Hum Mol Genet | 2022 |
| 35925453 | Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study. | Breast Cancer Res Treat | 2022 |
| 35291014 | A Systematic Review and Meta-Analysis of Smoking and Circulating Sex Hormone Levels Among Premenopausal Women. | Nicotine Tob Res | 2022 |
| 35258770 | Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer. | Annals of Surgical Oncology | 2022 |
| 34966897 | Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response. | Nat Cancer | 2021 |
| 34234117 | Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. | Nat Commun | 2021 |
| 33951110 | Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy. | PLoS One | 2021 |
| 33769540 | Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. | J Natl Cancer Inst | 2021 |
| 33713608 | Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. | Am J Hum Genet | 2021 |
| 32822287 | Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast | Journal of Clinical Oncology | 2021 |
| 34625570 | A careful reassessment of anthracycline use in curable breast cancer. | NPJ Breast Cancer | 2021 |
| 32852708 | Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients. | Breast Cancer Res Treat | 2020 |
| 31601552 | Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers. | Cancer Discov | 2020 |
| 32139271 | A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer. | Clinical Breast Cancer | 2020 |
| 32014370 | Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG). | Clin Breast Cancer | 2020 |
| 31935283 | A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry. | Blood Adv | 2020 |
| 31615937 | Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer. | Clin Cancer Res | 2020 |
| 33203854 | Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07). | Nat Commun | 2020 |
| 33199723 | Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains. | Nat Commun | 2020 |
| 32697890 | Testing considerations for phosphatidylinositol-3-kinase catalytic subunit alpha as an emerging biomarker in advanced breast cancer. | Cancer Medicine | 2020 |
| 31097597 | Role for polo-like kinase 4 in mediation of cytokinesis. | Proc Natl Acad Sci U S A | 2019 |
| 30520947 | Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines. | JAMA Oncol | 2019 |
| 30737380 | Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy. | Nat Commun | 2019 |
| 31147552 | Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy. | Nat Commun | 2019 |
| 29846104 | Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. | Arch Pathol Lab Med | 2018 |
| 30120700 | Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform. | Breast Cancer Research and Treatment | 2018 |
| 30485824 | Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines. | Cell Rep | 2018 |
| 29868978 | RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer. | Annals of Surgical Oncology | 2018 |
| 30572639 | CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer. | Cancers | 2018 |
| 30089602 | Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer. | Lung Cancer | 2018 |
| 29357906 | Body mass index at age 18Â years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis. | Breast Cancer Res | 2018 |
| 29244528 | Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast | Journal of Clinical Oncology | 2018 |
| 29846122 | Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. | J Clin Oncol | 2018 |
| 28123601 | Human-derived normal mesenchymal stem/stromal cells in anticancer therapies. | Journal of Cancer | 2017 |
| 28430825 | Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. | PLoS Genet | 2017 |
| 28377418 | Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. | Cancer Epidemiol Biomarkers Prev | 2017 |
| 28649645 | A functionally significant SNP in TP53 and breast cancer risk in African-American women. | NPJ Breast Cancer | 2017 |
| 27811012 | HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib. | Mol Cancer Ther | 2017 |
| 28086982 | Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis. | Breast Cancer Res | 2017 |
| 27587788 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. | Cancer Epidemiol Biomarkers Prev | 2016 |